(Q38104284)

28 August 2017

Evidence for a dysregulated immune system in the etiology of psychiatric disorders (English)

1 reference

28 August 2017

Sinead M Gibney

1

1 reference

PubMed ID

23645137

28 August 2017

Hemmo A Drexhage

series ordinal

2

1 reference

28 August 2017

5 May 2013

1 reference

Journal of Neuroimmune Pharmacology

28 August 2017

1 reference

28 August 2017

8

1 reference

28 August 2017

900-920

1 reference

28 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11481-013-9462-8

28 August 2017

0 references

cites work

Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokines as a precipitant of depressive illness: animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Maternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Altered T cell responses in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

In search of cellular immunophenotypes in the blood of children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Fetal infections and brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effects of prenatal infection on brain development and behavior: a review of findings from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Maternal autoantibodies in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The environment and susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prenatal infection and schizophrenia: a review of epidemiologic and translational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Serologic evidence of prenatal influenza in the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A case control study on psychiatric disorders in Hashimoto disease and Euthyroid Goitre: not only depressive but also anxiety disorders are associated with thyroid autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Extrapolating brain development from experimental species to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depression, stress and immunological activation: the role of cytokines in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Inflammation-associated depression: from serotonin to kynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The art of war: Innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Peripheral and central inflammation in autism spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Relationship between depression and C-reactive protein in a screening population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Synaptic dysfunction in depression: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokines as mediators of depression: what can we learn from animal studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Association of schizophrenia and autoimmune diseases: linkage of Danish national registers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Autoimmune diseases, bipolar disorder, and non-affective psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Differential monocyte responses to TLR ligands in children with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effect of the interleukin-1β gene on dorsolateral prefrontal cortex function in schizophrenia: a genetic neuroimaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Immune changes induced by electroconvulsive therapy (ECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Microglia biology in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Association between tendency towards depression and severity of rheumatoid arthritis from a national representative sample: the Medical Expenditure Panel Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prenatal inflammation impairs adult neurogenesis and memory related behavior through persistent hippocampal TGFβ1 downregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Dose-dependent effects of endotoxin on neurobehavioral functions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Microglia as a source and target of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prenatal exposure to lipopolysaccharide results in cognitive deficits in age-increasing offspring rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Central administration of murine interferon-α induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Do corticosteroids damage the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Autism and environmental genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Regulatory T cells increased while IL-1β decreased during antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokines and the nervous system. I: Expression and recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Modeling an autism risk factor in mice leads to permanent immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depressive-like behavior induced by tumor necrosis factor-α in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Activity loss and the onset of depressive symptoms: do some activities matter more than others?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Studies in the Childhood Psychoses I. Diagnostic Criteria and Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depression: an inflammatory illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokines and the brain: implications for clinical psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Elevated immune response in the brain of autistic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

In vivo immunomodulatory effects of clozapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Minocycline, schizophrenia and GluR1 glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depression in patients with rheumatoid arthritis: description, causes and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Adult schizophrenia following prenatal exposure to an influenza epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Minocycline as adjunctive therapy for schizophrenia: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Elevated cytokine levels in children with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depression, chronic diseases, and decrements in health: results from the World Health Surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Clinical effects of COX-2 inhibitors on cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Season of birth in schizophrenia. Evidence for confinement of an excess of winter births to patients without a family history of mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Raised levels of plasma interleukin-1beta in major and postviral depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A high prevalence of organ-specific autoimmunity in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Microglia in development: linking brain wiring to brain environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Immune involvement in schizophrenia and autism: etiology, pathology and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Maternal infection and autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

5-HT(1A) receptor and apoptosis contribute to interferon-α-induced "depressive-like" behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Brain-immune communication pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Is depression an inflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Autism: Definition, Neurobiology, Screening, Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Development in motion: helper T cells at work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Toll-like receptors in pregnancy disorders and placental dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Immunological dysfunction in schizophrenia: a systematic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Possible association between interleukin-1β gene and schizophrenia in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Schizophrenia and 1957 pandemic of influenza: meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

MHC class I: an unexpected role in neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Activation of the maternal immune system alters cerebellar development in the offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The macrophage theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokines mediated inflammation and decreased neurogenesis in animal models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Neuropoietic cytokines in normal brain development and neurodevelopmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Endogenous kynurenines as targets for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

High blood monocyte counts and neopterin levels in children with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Microglia in the cerebral cortex in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Neuroglial activation and neuroinflammation in the brain of patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

"Inflammatory" cytokines: neuromodulators in normal brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Nurr1 is not essential for the development of prepulse inhibition deficits induced by prenatal immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Functions of microglia in the central nervous system--beyond the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cytokines and cognition--the case for a head-to-toe inflammatory paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Association study between interleukin-1β gene (IL-1β) and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Increased affective ultrasonic communication during fear learning in adult male rats exposed to maternal immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Endotoxin produces a depressive-like episode in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Transfer of inflammatory cytokines across the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Cerebrospinal fluid and serum markers of inflammation in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Relation of stressors and depressive symptoms to clinical progression of viral illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

The relationship of depression and stressors to immunological assays: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Glucocorticoids, cytokines and brain abnormalities in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Interleukin-1 Gene Complex in Schizophrenia: An Association Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9462-8

Common variants on chromosome 6p22.1 are associated with schizophrenia

21 January 2018

1 reference

12 December 2020

Association between prenatal exposure to poliovirus infection and adult schizophrenia.

1 reference

12 December 2020

Serum cytokine concentrations in patients with schizophrenia

1 reference

12 December 2020

Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia

1 reference

12 December 2020

Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?

1 reference

12 December 2020

Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics

1 reference

12 December 2020

Neuroinflammation in schizophrenia-related psychosis: a PET study.

1 reference

12 December 2020

Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene

1 reference

12 December 2020

Depressive symptoms and white blood cell count in coronary heart disease patients: prospective findings from the Heart and Soul Study.

1 reference

12 December 2020

Expression of cytokine receptors in cultured neuronal and glial cells

1 reference

12 December 2020

Maternal infection during pregnancy and schizophrenia

1 reference

12 December 2020

A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase

1 reference

12 December 2020

Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression

1 reference

12 December 2020

Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice.

1 reference

12 December 2020

[Role of cytokines in the central nervous system]

1 reference

12 December 2020

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

1 reference

12 December 2020

Genes for interleukin-2 receptor beta chain, interleukin-1 beta, and schizophrenia: no evidence for the association or linkage

1 reference

12 December 2020

Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update.

1 reference

12 December 2020

Maternal cytokine levels during pregnancy and adult psychosis

1 reference

12 December 2020

Common variants conferring risk of schizophrenia

1 reference

12 December 2020

Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms

1 reference

12 December 2020

Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression

1 reference

12 December 2020

Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors

1 reference

12 December 2020

1 reference

12 December 2020

Detection of two new polymorphic sites in the human interleukin-1 beta gene: lack of association with schizophrenia in a French population.

1 reference

12 December 2020

Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy

1 reference

12 December 2020

Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress.

1 reference

12 December 2020

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

1 reference

12 December 2020

Impaired monocyte activation in schizophrenia

1 reference

12 December 2020

Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome

1 reference

12 December 2020

Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder

1 reference

12 December 2020

Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia

1 reference

12 December 2020

The role of IL-2 and soluble IL-2R in depression and antidepressant response.

1 reference

12 December 2020

Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection

1 reference

12 December 2020

10.1007/S11481-013-9462-8

Identifiers

DOI

1 reference

PubMed ID

23645137

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23645137